Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack P Antel

Showing results (1-10 of 165) with videos related to

Pageof 17
Sort By:
Current Neurology and Neuroscience Reports|October 30, 2008
The CNS as a therapeutic target in multiple sclerosisJack P Antel
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 2025
Neuroimmune interactions: How past lessons can inform the present and future of MS careAdil Harroud, Jack P Antel
Neurology|November 24, 2004
Does interferon beta help in secondary progressive MS?Jeffrey A Cohen, Jack P Antel
Current Opinion in Neurology|April 2, 2016
Central nervous system inflammation across the age spanAmit Bar-Or, Jack P Antel
Clinical Neurology and Neurosurgery|May 27, 2008
Central nervous system effects of current and emerging multiple sclerosis-directed immuno-therapiesJack P Antel, Veronique E Miron
The New England Journal of Medicine|July 11, 2003
Do myelin-directed antibodies predict multiple sclerosis?Jack P Antel, Amit Bar-Or
Current Drug Targets|October 2, 2015
Sphingosine-1-Phosphate Receptors in the Central Nervous and Immune SystemsLuke M Healy, Jack P Antel
Journal of Autoimmunity|April 15, 2005
Th1 and Th2 lymphocyte migration across the human BBB is specifically regulated by interferon beta and copolymer-1Alexandre Prat, Katarzyna Biernacki, Jack P Antel
Neural Regeneration Research|February 5, 2026
Oligodendrocytes under stress in multiple sclerosisChao Weng, Florian Pernin, Jack P Antel
Biochimica Et Biophysica Acta|October 5, 2010
Cells of the oligodendroglial lineage, myelination, and remyelinationVeronique E Miron, Tanja Kuhlmann, Jack P Antel
Pageof 17

Showing results (1-10 of 165) with videos related to

Sort By:
Pageof 17
Current Neurology and Neuroscience Reports|October 30, 2008
The CNS as a therapeutic target in multiple sclerosisJack P Antel
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 2025
Neuroimmune interactions: How past lessons can inform the present and future of MS careAdil Harroud, Jack P Antel
Neurology|November 24, 2004
Does interferon beta help in secondary progressive MS?Jeffrey A Cohen, Jack P Antel
Current Opinion in Neurology|April 2, 2016
Central nervous system inflammation across the age spanAmit Bar-Or, Jack P Antel
Clinical Neurology and Neurosurgery|May 27, 2008
Central nervous system effects of current and emerging multiple sclerosis-directed immuno-therapiesJack P Antel, Veronique E Miron
The New England Journal of Medicine|July 11, 2003
Do myelin-directed antibodies predict multiple sclerosis?Jack P Antel, Amit Bar-Or
Current Drug Targets|October 2, 2015
Sphingosine-1-Phosphate Receptors in the Central Nervous and Immune SystemsLuke M Healy, Jack P Antel
Journal of Autoimmunity|April 15, 2005
Th1 and Th2 lymphocyte migration across the human BBB is specifically regulated by interferon beta and copolymer-1Alexandre Prat, Katarzyna Biernacki, Jack P Antel
Neural Regeneration Research|February 5, 2026
Oligodendrocytes under stress in multiple sclerosisChao Weng, Florian Pernin, Jack P Antel
Biochimica Et Biophysica Acta|October 5, 2010
Cells of the oligodendroglial lineage, myelination, and remyelinationVeronique E Miron, Tanja Kuhlmann, Jack P Antel
Pageof 17